Company Registration No. SC296459 (Scotland)
HIGHLAND BIOSCIENCES LTD
Annual Report and Statement of Accounts
For the Period from 31 December 2024 to 30 December 2025

HIGHLAND BIOSCIENCES LTD

Annual report and statement of accounts for the period ending 30/12/2025

CONTENTS PAGE
Company information 2
Balance Sheet 3
- 1 -

HIGHLAND BIOSCIENCES LTD

Financial statement for the period ended 30/12/2025

Company Information

1 Statutory Information
Company Number SC296459
Registered Office NESS HOUSE
DUNCANSTON
DINGWALL
ROSS-SHIRE
IV7 8JD
2 Directors
Directors who held office during the period were:
DAY, Emma Vanessa Jayne, Mrs.   
DAY, Richard Michael, Dr   
3 Principal Activity
The principal activity of the company is the research and development of medical diagnostic devices, including a point of care blood coagulation test (Coaguscan) and related feasibility-stage projects. The company also generates revenue from professional and technical consulting services.
4 Employees
Average number of employees, including directors, during the year was as follows:
2025 2
2024 2
- 2 -

HIGHLAND BIOSCIENCES LTD

Financial statement for the period ended 30/12/2025

Statement of Financial Position

2025 2024
£ £
Fixed Assets 14,939 19,788
Current Assets 143,770 159,278
Creditors: amounts falling due within one year (27,523) (16,445)
Net Current Assets 116,247 142,833
Total assets less current liabilities 131,186 162,621
Creditors: amounts falling due after one year (23,748) (31,253)
Net Assets 107,438 131,368
Capital and reserves 107,438 131,368
For the period ending 30/12/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 10 April 2026
Dr. R. M. Day
Company Registration No. SC296459
- 3 -